alcohol and glp-1 A preliminary study of the physiological perceptual effects of receptor agonists during consumption in people with obesity GLP-1s Hold Promise as Treatment
Description
95% CI, 0.380.99), as well as a decrease in the rate of MACE by 26% (79)
Diabetes 44 (9), 11261131
Sardu C, Santamaria M, Funaro S, Sacra C, Barbieri M, Paolisso P, Marfella R, Paolisso G, Rizzo MR
Other important contributing factors are eating disorders and depression, which are more common in patients with T1D compared to the overall population ( Figure 1 Obesity increases the risk of obesity-related as well as diabetes-related complications in patients with T1D, including micro- and macrovascular complications, various types of cancer, and overall mortality ( Figure 1 )
Qsymia is not a GLP-1
